pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 30·1 min read
save

Anthropic launches Claude Science, AI platform aimed at bioscience and drug discovery

Jun 30, 2026·read at Endpoints ↗Positive

Anthropic, known for its Claude Code AI coding assistant, announced a new product called Claude Science aimed at the life‑science sector.

The platform is designed to help biopharma researchers with tasks such as data analysis, hypothesis generation and drug‑discovery workflows, leveraging the same large‑language‑model technology.

Anthropic also said it will start its own internal drug‑development programs using Claude Science, signalling a move from pure AI services into direct participation in pharmaceutical research.

The announcement marks the company's expansion beyond software programming into the biotech arena, though details on pricing or partnerships were not provided.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Anthropic debuts Claude Science, an AI product for bioscience”

read at Endpoints ↗
95 words · retrieved Jul 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 12h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 15h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 15h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 16h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 17h agoHealth tech investors are looking at bigger betsEndpoints